Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-08-05 Sale | 2026-08-05 6:59 pm | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 4,356 | $25 | $108,900 | 179,537 (Direct) | View |
| 2026-08-04 Sale | 2026-08-05 06:39 am | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 4,111 | $24.36 | $100,142 | 117,227 (Direct) | View |
| 2026-08-04 Sale | 2026-08-04 9:41 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 4,761 | $24.36 | $115,989 | 40,166 (Direct) | View |
| 2026-08-03 Sale | 2026-08-03 5:51 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 16,589 | $23.05 | $382,358 | 131,934 (Direct) | View |
| 2026-07-30 Sale | 2026-07-30 5:58 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 2,845 | $23.38 | $66,524 | 115,489 (Direct) | View |
| 2026-07-30 Sale | 2026-07-30 5:56 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,847 | $23.38 | $89,954 | 90,474 (Direct) | View |
| 2026-07-30 Sale | 2026-07-30 5:50 pm | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 3,847 | $23.38 | $89,954 | 191,900 (Direct) | View |
| 2026-07-02 Sale | 2026-07-02 6:02 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 11,008 | $23.56 | $259,366 | 142,190 (Direct) | View |
| 2026-06-25 Sale | 2026-06-25 6:49 pm | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 5,394 | $20 | $107,880 | 115,005 (Direct) | View |
| 2026-06-25 Sale | 2026-06-25 6:38 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 28,935 | $20.06 | $580,506 | 147,977 (Direct) | View |
| 2026-06-02 Sale | 2026-06-02 7:14 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 8,148 | $16.6 | $135,253 | 18,800 (Direct) | View |
| 2026-05-05 Sale | 2026-05-05 7:53 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 14,055 | $16.6 | $233,319 | 37,592 (Direct) | View |
| 2026-05-04 Sale | 2026-05-04 6:10 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 8,148 | $16.96 | $138,210 | 18,305 (Direct) | View |
| 2026-05-01 Sale | 2026-05-01 5:50 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,394 | $16.76 | $90,407 | 26,453 (Direct) | View |
| 2026-04-30 Sale | 2026-04-30 5:38 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 2,388 | $16.65 | $39,749 | 89,514 (Direct) | View |
| 2026-04-30 Sale | 2026-04-30 5:37 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,214 | $16.65 | $53,498 | 69,714 (Direct) | View |
| 2026-04-30 Sale | 2026-04-30 5:35 pm | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 3,214 | $16.65 | $53,498 | 158,266 (Direct) | View |
| 2026-04-02 Sale | 2026-04-02 7:02 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 8,148 | $15.24 | $124,149 | 26,453 (Direct) | View |
| 2026-03-02 Sale | 2026-03-02 7:05 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 8,148 | $15.44 | $125,793 | 34,601 (Direct) | View |
| 2026-02-09 Sale | 2026-02-09 7:47 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 14,261 | $16.66 | $237,618 | 42,749 (Direct) | View |
| 2026-01-30 Sale | 2026-01-30 8:39 pm | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 3,661 | $16.6 | $60,767 | 91,902 (Direct) | View |
| 2026-01-30 Sale | 2026-01-30 8:38 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 4,421 | $16.6 | $73,381 | 103,485 (Direct) | View |
| 2026-01-30 Sale | 2026-01-30 8:36 pm | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 4,895 | $16.6 | $81,249 | 130,147 (Direct) | View |
| 2026-01-20 Sale | 2026-01-20 7:57 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,760 | $18.42 | $69,273 | 59,540 (Direct) | View |
| 2025-12-18 Sale | 2025-12-18 6:08 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,760 | $17.9 | $67,314 | 63,300 (Direct) | View |
| 2025-11-24 Sale | 2025-11-24 6:06 pm | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 37,600 | $17.07 | $641,697 | 67,060 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-08-05 Exercise | 2026-08-05 6:59 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 4,356 | $1.86 | 179,537 (Direct) | View |
| 2026-08-05 Exercise | 2026-08-05 6:59 pm | N/A 2029-08-28 | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 4,356 | $0 | 179,537 (Direct) | View |
| 2026-08-03 Exercise | 2026-08-03 5:51 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,787 | $8.72 | 131,934 (Direct) | View |
| 2026-08-03 Exercise | 2026-08-03 5:51 pm | N/A 2034-02-12 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,787 | $0 | 131,934 (Direct) | View |
| 2026-07-30 Exercise | 2026-07-30 5:58 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 10,180 | $0 | 115,489 (Direct) | View |
| 2026-07-30 Exercise | 2026-07-30 5:56 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 10,180 | $0 | 90,474 (Direct) | View |
| 2026-07-30 Exercise | 2026-07-30 5:50 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 10,180 | $0 | 191,900 (Direct) | View |
| 2026-07-02 Exercise | 2026-07-02 6:02 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,221 | $1.86 | 142,190 (Direct) | View |
| 2026-07-02 Exercise | 2026-07-02 6:02 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 5,787 | $8.72 | 142,190 (Direct) | View |
| 2026-07-02 Exercise | 2026-07-02 6:02 pm | N/A 2029-09-30 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 11,008 | $0 | 142,190 (Direct) | View |
| 2026-06-25 Exercise | 2026-06-25 6:38 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 15,602 | $8.72 | 147,977 (Direct) | View |
| 2026-06-25 Exercise | 2026-06-25 6:38 pm | N/A 2030-02-26 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 28,935 | $0 | 147,977 (Direct) | View |
| 2026-06-25 Exercise | 2026-06-25 6:38 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 13,333 | $7.26 | 147,977 (Direct) | View |
| 2026-06-02 Exercise | 2026-06-02 7:14 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,422 | $1.86 | 18,800 (Direct) | View |
| 2026-06-02 Exercise | 2026-06-02 7:14 pm | N/A 2029-09-30 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,422 | $0 | 18,800 (Direct) | View |
| 2026-05-15 Option Award | 2026-05-15 5:56 pm | N/A 2036-05-14 | Nurix Therapeutics Inc. | NRIX | Silva Paul M Director | 31,250 | $0 | 31,250 (Direct) | View |
| 2026-05-15 Option Award | 2026-05-15 5:55 pm | N/A 2036-05-14 | Nurix Therapeutics Inc. | NRIX | Saltzman Edward C Director | 31,250 | $0 | 31,250 (Direct) | View |
| 2026-05-15 Option Award | 2026-05-15 5:52 pm | N/A 2036-05-14 | Nurix Therapeutics Inc. | NRIX | Reinsdorf Judith A Director | 31,250 | $0 | 31,250 (Direct) | View |
| 2026-05-15 Option Award | 2026-05-15 5:51 pm | N/A 2036-05-14 | Nurix Therapeutics Inc. | NRIX | Lacey David L. Director | 31,250 | $0 | 31,250 (Direct) | View |
| 2026-05-15 Option Award | 2026-05-15 5:49 pm | N/A 2036-05-14 | Nurix Therapeutics Inc. | NRIX | Kapur Anil Director | 31,250 | $0 | 31,250 (Direct) | View |
| 2026-05-15 Option Award | 2026-05-15 5:46 pm | N/A 2036-05-14 | Nurix Therapeutics Inc. | NRIX | DANSEY ROGER D Director | 31,250 | $0 | 31,250 (Direct) | View |
| 2026-05-15 Option Award | 2026-05-15 5:42 pm | N/A 2036-05-14 | Nurix Therapeutics Inc. | NRIX | Baynes Roy D. Director | 31,250 | $0 | 31,250 (Direct) | View |
| 2026-05-15 Option Award | 2026-05-15 5:37 pm | N/A 2036-05-14 | Nurix Therapeutics Inc. | NRIX | GREGORY JULIA P Director | 31,250 | $0 | 31,250 (Direct) | View |
| 2026-04-30 Exercise | 2026-04-30 5:38 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 8,608 | $0 | 89,514 (Direct) | View |
| 2026-04-30 Exercise | 2026-04-30 5:37 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 8,608 | $0 | 69,714 (Direct) | View |
| 2026-04-30 Exercise | 2026-04-30 5:35 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 8,608 | $0 | 158,266 (Direct) | View |
| 2026-02-10 Option Award | 2026-02-10 6:09 pm | N/A 2036-02-09 | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 136,625 | $0 | 136,625 (Direct) | View |
| 2026-02-10 Option Award | 2026-02-10 5:55 pm | N/A 2036-02-09 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 136,625 | $0 | 136,625 (Direct) | View |
| 2026-02-10 Option Award | 2026-02-10 5:50 pm | N/A 2036-02-09 | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 136,625 | $0 | 136,625 (Direct) | View |
| 2026-02-10 Option Award | 2026-02-10 5:43 pm | N/A 2036-02-09 | Nurix Therapeutics Inc. | NRIX | SANDS ARTHUR T President, CEO | 562,500 | $0 | 562,500 (Direct) | View |
| 2026-02-03 Exercise | 2026-02-03 9:12 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 31,333 | $0.84 | 115,005 (Direct) | View |
| 2026-02-03 Exercise | 2026-02-03 9:12 pm | N/A 2026-02-10 | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 31,333 | $0 | 115,005 (Direct) | View |
| 2026-01-30 Exercise | 2026-01-30 8:39 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | van Houte Hans Chief Financial Officer | 11,496 | $0 | 91,902 (Direct) | View |
| 2026-01-30 Exercise | 2026-01-30 8:38 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 10,534 | $0 | 103,485 (Direct) | View |
| 2026-01-30 Exercise | 2026-01-30 8:36 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Hansen Gwenn Chief Scientific Officer | 11,816 | $0 | 130,147 (Direct) | View |
| 2026-01-20 Exercise | 2026-01-20 7:57 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,760 | $1.86 | 59,540 (Direct) | View |
| 2026-01-20 Exercise | 2026-01-20 7:57 pm | N/A 2029-09-30 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,760 | $0 | 59,540 (Direct) | View |
| 2025-12-18 Exercise | 2025-12-18 6:08 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,760 | $1.86 | 63,300 (Direct) | View |
| 2025-12-18 Exercise | 2025-12-18 6:08 pm | N/A 2029-09-30 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 3,760 | $0 | 63,300 (Direct) | View |
| 2025-11-24 Exercise | 2025-11-24 6:06 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 37,600 | $1.86 | 67,060 (Direct) | View |
| 2025-11-24 Exercise | 2025-11-24 6:06 pm | N/A 2029-09-30 | Nurix Therapeutics Inc. | NRIX | Ring Christine Chief Legal Officer | 37,600 | $0 | 67,060 (Direct) | View |
| 2025-11-06 Option Award | 2025-11-10 07:19 am | N/A 2035-11-06 | Nurix Therapeutics Inc. | NRIX | DANSEY ROGER D Director | 50,000 | $0 | 50,000 (Direct) | View |